Association of vitamin D supplementation with complications and prognosis of patients with COVID-19
DOI:
https://doi.org/10.33064/iycuaa2022853099Keywords:
COVID-19, Vitamin D, Complications, PrognosisAbstract
COVID-19 is an initial pathology detected by the outbreak of cases of atypical pneumonia of unknown etiology in Wuhan, China in 2019 and has spread worldwide, causing severe acute respiratory syndrome. The morbidity and mortality of this pathology are high in Mexico, becoming a priority to implement initiatives that allow modulating the current course of this pathology. Vitamin D has an important immune role against respiratory infections, and its deficiency has been related to the pathogenesis of the virus; mortality from COVID-19 is complex due to other factors that intervene in its spread and appearance of complications. However, the study of vitamin D supplementation and its relationship with the outcome of this disease should be considered.
Downloads
Metrics
References
• Alcántara, A. (2016). Vitamina D y dolor crónico, Rev. Soc. Esp. Dolor. 23(4), 211- 14.
• Bergman, P. (2020). The link between vitamin D and COVID‐19: distinguishing facts from fiction. JIM editorial comment, The Association for the Publication of the Journal of Internal Medicine. 289(1), 131-133.
• Cervantes, G., Cervantes, E., Cervantes, L., Cervantes, G., Cervantes, G., Ramírez, S., Martínez, M. et al. (2020). Consideraciones nutricionales en pacientes hospitalizados con COVID-19: lo que el clínico debe saber. Med. Int. Méx. 36(4), 562-569.
• Comunicado Técnico diario COVID-19 2021, 10, 20. https://www.gob.mx/salud/documentos/coronavirus-covid-19-comunicado-tecnico-diario-238449
• Crane, M., Clem, C., Payne, P. & Fiering, S. (2020). Vitamin D Deficiency and Air Pollution Exacerbate COVID-19 Through Suppression of Antiviral Peptide LL37. Frontiers in Public Health. Vol.8, 1-5.
• Cucalón, J., Blay, M., Zumeta, J. & Blay, V. (2019). Actualización en el tratamiento con colecalciferol en la hipovitaminosis D desde atención primaria. Med Gen Fam. 8(2), 68-78.
• Fuentes, H., Aguilera, E. & González, C. (2018). The rol of vitamin D in the prevention of falls among subjects with sarcopenia. Rev. chil. Nutr. 45(3), 279-284.
• Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J. & Hu, Y. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 395(10223), 497-506.
• Kenneth, E., Thenappan, T. & Bhargava, M. (2020). Does vitamin D deficiency increase the severity of COVID-19?. Royal college of physicians, Clinical Medicine. 20(4), e107-e108.
• Laird, E. & Kenny, R. (2020). Vitamin D deficiency in Ireland: Implications for COVID-
• 19. Clinical Medicine. 20(4), e107-8.
• Li, X., Geng, M., Peng, Y., Meng, L. & Lu, S. (2020). Molecular immune pathogenesis and diagnosis of COVID-19. J Pharm Anal. 10(2), 102-108.
• López, J. & Roman, L. (2020). Verdades y mitos sobre el tratamiento nutricional en el COVID-19 (La nutrición y la evidencia científica en el COVID-19). Servicio de Endocrinología y Nutrición. 14(2), 85-96.
• Malek, A. (2020). A brief review of interplay between vitamin D and angiotensin- converting enzyme 2: Implications for a potential treatment for COVID-19. Rev Med Virol. Vol.30:e2119, 1-6.
• Mansur, J., Tajer, C., Mariani, J., Inserra, F., Ferder, L. & Manucha, W. (2020). Vitamin D high doses supplementation could represent a promising alternative to prevent or treat COVID-19 infection. Clin Investig Arterioscler. 32(6), 267-277.
• Mitchell F. (2020). Vitamin-D and COVID-19: do deficient risk a poorer outcome?.
• The lancet Diabetes & endocrinology. 8(7), 570.
• Nolasco, R., Setsuo, S. & Jardim, J. (2020). Reasons to avoid vitamin D deficiency during COVID-19 pandemic. Archives of Endocrinology and Metabolism. 64(5), 498-506.
• Organización Mundial de la Salud (OMS), ed. (11 de marzo de 2020). “Alocución de apertura del Director General de la OMS en la rueda de prensa sobre la COVID-19 celebrada el 11 de marzo de 2020”.
• Pahar, B., Madonna, S., Das, A., Albanesi, C. & Girolomoni, G. (2020). Immunomodulatory Role of the Antimicrobial LL-37. Vaccines. 8(517), 1-19.
• Pereira. M., Gomes, J., Queiroz, G., Barbosa, D., Oliveira, A. (2019). Epidemiology of vitamin D insufficiency and deficiency in a population in a sunny country: Geospatial metaanalysis in Brazil. Crit Rev Food Sci Nutr. 59(13), 2102-2109.
• Piñeiro, D. & Hernández, J. (2020). Relación de los niveles de la vitamina D con las tasas de letalidad en la COVID-19: Fundamentos, evidencias, y recomendaciones que se pueden asumir. BOLETÍN CIENTÍFICO DEL CIMEQ. ACTUALIZACIÓN MÉDICA DEL SARS‐COV‐2. Vol. 1(13), 1-2.
• Quiroz, C., Pareja, A., Valencia, E., Enríquez, Y., De León, J. & Aguilar, P. (2020). Un nuevo coronavirus, una nueva enfermedad: COVID-19. Horiz. Med. (Lima). 20 (2), e1208.
• Rhodes, J., Dunstan, F., Laird, E., Subramanian, S., Kenny, R. (2020). COVID-19 mortality increases with northerly latitude after adjustment for age suggesting a link with ultraviolet and vitamin DBMJ Nutrition, Prevention & Health. BMJNPH. 0 (0), 1- 3.
• Rodríguez, A., Montelongo, E., Martínez, A., Puente, A. & Reyes, R. (2020). La deficiencia de vitamina D es un factor de riesgo de mortalidad en pacientes con COVID-19. Rev Sanid Milit Mex. 74(1-2), 106-13.
• Romo, A., Reyes, C. & Janka, M. (2020). El rol de la nutrición en la enfermedad por coronavirus 2019 (COVID-19). Rev. Méx endocrino metab Nutr. Vol. 7, 132-42.
• Rosselli, D. (2020). Epidemiología de las pandemias. Med. 42(2), 168-174.
• Seijo, M. & Oliveri, B. (2020). Vitamina D en la época del COVID-19. Osteoporosis y enfermedades óseas. Actual. Osteol. 16(2), 1-15.
• Slominski, R., Stefan, J., Athar, M., Holick, M., Jetten, A., Reman, C. & Slominski,
• (2020). COVID‐19 and Vitamin D: A lesson from the skin. Exp Dermatol.Vol.29, 885- 890.
• Tay, M., Poh, C., Rénia, L., MacAry, P. & Ng, L. (2020). The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol. Vol.20, 363-374.
• Teymoori, M. & Marashi, S. (2020). Vitamin D and Covid-19: From potential therapeutic effects to unanswered questions. Rev Med Virol. e2159, 1-16.
• Ulloa, R., Ivankovich, G. & Yamazaki, M. (2020). Síndrome inflamatorio multisistémico asociado a COVID-19 en niños y adolescentes: un llamado al diagnóstico. Rev. chil. Infectol. 37(3), 199-201.
• Van Doremalen, N., Bushmaker, T., Morrisken, D., Holbrook, M., Gamble, A., Williamson, B., Tamin, A., et al. (2020). Aerosol and surface stability of HCoV-19 (SARSCoV-2) compared to SARS-CoV-1. N Engl J Med. 382(16). 1-2.
• Villegas, M. (2020). Pandemia de COVID-19: pelea o huye. Rev Exp Med.6(1), 3- 4.
• Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X. & Zhang, J. (2020). Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan. China. JAMA - J Am Med Assoc, 323(11), 1061-69.
• William, B., Henry, L., Sharon, L., Carole, A., Christine, B., Jennifer, L. & Harjit, P. (2020). Evidencia de que la suplementación con vitamina D podría reducir el riesgo de infecciones y muertes por influenza y COVID-19. Nutrients. 12(988), 1-19.
• Xolair, Core. & Data, Sheet. (2019). Version 3.1. Effective Date: 11-Dec-2019, 33. https://www.novartis.com.sg/sites/www.novartis.com.sg/files/product-info/Xolair-Dec2019.SINv1-app100521-pdf.pdf
• Xu, Y., Baylink, D., Chen, C., Reeves, M., Xiao, J., Lacy, C., Lau, E., et al. (2020). The importance of vitamin d metabolism as a potential prophylactic, immunoregulatory and neuroprotective treatment for COVID-19. J Transl Med. 18(322), 1-12.
• Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., et. al. (2020). Un nuevo coronavirus de pacientes con neumonía en China. N. Engl J Med. 382(8), 727-33.
Downloads
Published
License
Copyright (c) 2022 Gilda Margarita González-Guerrero, Alexa Michelle Pérez-Cuellar, Alejandra López-Rocha, Leslie Hurtado-Vidaurri, Ricardo Ernesto Ramírez-Orozco
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Las obras publicadas en versión electrónica de la revista están bajo la licencia Creative Commons Atribución-NoComercial-CompartirIgual 4.0 Internacional (CC BY-NC-SA 4.0)
